Predictive factors for sarcopenia and malabsorption in high risk surgical oncological patients after cytoreductive surgery and HIPEC procedure

Predictive factors for sarcopenia and malabsorption in high risk surgical oncological patients after cytoreductive surgery and HIPEC procedure - Sarcopenia and Malabsorption in HIPEC patients (SMAL-HIPEC)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42927

Enrollment

Registered

2016-10-20

Start date

2017-10-05

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle loss and HIPEC procedure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients > 18 years that undergo CRS and HIPEC procedure at the University Medical Center Groningen (UMCG)

Exclusion criteria

Exclusion criteria: All patients not eligible for CRS and HIPEC procedure not fit for surgery or unable to provide written consent or inability to fill out questionnaires

Design outcomes

Primary

Measure	Time frame
Sarcopenia (Muscle loss), measured by the psoas muscle density is the primary outcome	—

Secondary

Measure	Time frame
Malabsorption, measured by the fecal energy by bomb calorimetry [kcal/d] is the secondary outcome. Other endpoints are anastomic leakage, pneumonia, infection, length of hospital stay, readmission rate, and one-year survival.	—

Countries

Netherlands

Outcome results